Proteomics to better understand the role of per diem expenses in cardiovascular arrhythmias
The department of Preventive Medicine of the University of Navarra has received funding for a project on proteomics to be developed at partnership with the Proteomics Unit of Navarrabiomed. The project has been one of the programs of study selected in the recent public call of the network of Proteomics of the high school of Health Carlos III.
The funded project , degree scroll "Proteomics and recurrence of paroxysmal atrial fibrillation: a pilot study", has been awarded to Dr. Cristina Razquin and is part of the essay PREDIMAR, in which Drs. Miguel Ruiz-Canela (researcher principal in Navarra), Miguel Ángel Martínez González, Leticia Goñi and Victor de la O are active members. Doctors Jokin Fernández and Enrique Santamaría will coordinate the analysis of the samples at NavarraBiomed.
The study "PREVENTION with per diem expenses Mediterranean of Recurrent Arrhythmias" (PREDIMAR) was launched with the aim of preventing the recurrence of arrhythmias in patients with paroxysmal or persistent atrial fibrillation who undergo ablation. Cardiologists from the Clinica Universidad de Navarra (Drs García-Bolao and Ramos), Granada (Dr. Luis Tercedor) and Alicante (Dr. José Luis Ibañez) are participating in this essay , with cardiologists Jesús Almendral and M. Teresa Barrio from the Montepríncipe hospital in Madrid as coordinators.
Proteomics allows the large-scale study of proteins in our body. Dr. Razquin points out that the funded study "will try to find serum proteins that are capable of differentiating participants with paroxysmal atrial fibrillation who recur from those who do not. This would help to find possible altered mechanisms in those patients who recur, thus opening up new avenues of research and treatments". Furthermore, as Dr. Ruiz-Canela emphasizes, "this study will open up new funding possibilities to see the effect of the Mediterranean per diem expenses on serum protein levels and whether these changes are related to the recurrence of atrial fibrillation".